Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trialNature MedicineJuly 21, 202210.1038/s41591-022-01897-xCited by 493SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis